Obesity and target organ damage: the heart

被引:70
作者
Schunkert, H [1 ]
机构
[1] Univ Regensburg, Klin & Poliklin Innere Med 2, Klinikum, D-93053 Regensburg, Germany
关键词
obesity; left ventricular hypertrophy; cardiac remodelling; fat mass; hypertension;
D O I
10.1038/sj.ijo.0802214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In most patients, coronary atherosclerosis or congestive heart failure develop as an integrated response to multiple cardiovascular risk factors. Obesity increases the prevalence of most cardiovascular risk factors and is the predominant cause of diabetes mellitus and arterial hypertension. Moreover, obesity shifts the manifestation of these risk factors to younger age groups, such that subsequent damage results prematurely in clinically overt cardiac diseases. In addition, due to clustering of obesity-related risk factors, obesity may amplify the risk by synergistic mechanisms acting in parallel. Finally, an elevated body mass index (BMI) results in an increase in heart rate and blood volume, as well as increased systolic and diastolic blood pressure. These changes affect cardiac geometry and mass in addition to the alterations of the coronary vasculature. At the population level, the role of obesity in promoting multiple risk factors and, subsequently, the development of heart diseases cannot be underestimated. In individual patients, however, the clinical presentation may be dominated by obesity-related hypertension, diabetes, metabolic and inflammatory derangements or clinical symptoms of heart failure or coronary artery disease. Weight reduction remains a crucial component of the therapeutic strategy to ameliorate insulin resistance, hypertension and left ventricular hypertrophy, among other risk factors, with profound implications for the individual's prognosis.
引用
收藏
页码:S15 / S20
页数:6
相关论文
共 47 条
[1]   Annual deaths attributable to obesity in the United States [J].
Allison, DB ;
Fontaine, KR ;
Manson, JE ;
Stevens, J ;
VanItallie, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1530-1538
[2]   Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss [J].
Alpert, MA ;
Terry, BE ;
Mulekar, M ;
Cohen, MV ;
Massey, CV ;
Fan, TM ;
Panayiotou, H ;
Mukerji, V .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (06) :736-740
[3]   COAGULATION, FIBRINOLYSIS AND HEMORHEOLOGY IN PREMENOPAUSAL OBESE WOMEN WITH DIFFERENT BODY-FAT DISTRIBUTION [J].
AVELLONE, G ;
DIGARBO, V ;
CORDOVA, R ;
RANELI, G ;
DESIMONE, R ;
BOMPIANI, GD .
THROMBOSIS RESEARCH, 1994, 75 (03) :223-231
[4]   Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents [J].
Balagopal, P ;
Sweeten, S ;
Mauras, N .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 282 (04) :E899-E904
[5]   Exercise and weight loss reduce blood pressure in men and women with mild hypertension - Effects on cardiovascular, metabolic, and hemodynamic functioning [J].
Blumenthal, JA ;
Sherwood, A ;
Gullette, ECD ;
Babyak, M ;
Waugh, R ;
Georgiades, A ;
Craighead, LW ;
Tweedy, D ;
Feinglos, M ;
Appelbaum, M ;
Hayano, J ;
Hinderliter, A .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (13) :1947-1958
[6]   Economic costs of obesity and inactivity [J].
Colditz, GA .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1999, 31 (11) :S663-S667
[7]   Postprandial triglyceride response in visceral obesity in men [J].
Couillard, C ;
Bergeron, N ;
Prud'homme, D ;
Bergeron, J ;
Tremblay, A ;
Bouchard, C ;
Mauriège, P ;
Després, JP .
DIABETES, 1998, 47 (06) :953-960
[8]   OBESITY AND CARDIAC-FUNCTION [J].
DEDIVITIIS, O ;
FAZIO, S ;
PETITTO, M ;
MADDALENA, G ;
CONTALDO, F ;
MANCINI, M .
CIRCULATION, 1981, 64 (03) :477-482
[9]   Modifiable cardiovascular risk factors in adults with diabetes - Prevalence and missed opportunities for physician counseling [J].
Egede, LE ;
Zheng, DY .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (04) :427-433
[10]  
Erdmann J, 2001, CIRCULATION, V104, P1